ReviewMayo Clinic proceedings2011
Inflammatory bowel disease: perioperative pharmacological considerations.
Review in Mayo Clinic proceedings, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.
- Preoperative optimization of patients with inflammatory bowel disease undergoing gastrointestinal surgery: a systematic review.International journal of colorectal disease · 2017Pooled it
- Chitosan nanoparticles of rutin mitigated histological changes induced in DNCB-induced colitis by enhanced modulation of inflammation and oxidative stress.Journal of molecular histology · 2025Article
- Preoperative medication management turnkey order set for nonemergent adult cardiac surgery.JTCVS open · 2024Article
- Peri-Operative Optimization of Patients with Crohn's Disease.Current gastroenterology reports · 2024Review
- Clinical outcomes and perioperative morbidity and mortality following segmental resections of the colon for Crohn's colitis.International journal of colorectal disease · 2024Article
- Perioperative Assessment and Optimization in Major Colorectal Surgery: Medication Management.Clinics in colon and rectal surgery · 2023Review
- Management of Enterovesical Fistula in a Patient with Crohn's Disease: A Case Report and Literature Review.Diagnostics (Basel, Switzerland) · 2023Article
- Purine-Induced IFN-γ Promotes Uric Acid Production by Upregulating Xanthine Oxidoreductase Expression.Frontiers in immunology · 2022Article
- Protective effect of galangin against dextran sulfate sodium (DSS)-induced ulcerative colitis in Balb/c mice.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2019Article
- A risk score model of 30-day readmission in ulcerative colitis after colectomy or proctectomy.Clinical and translational gastroenterology · 2018Article
- [Perioperative handling of immunosuppressive therapy].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2018Review
- Perioperative Considerations in Crohn Disease and Ulcerative Colitis.Clinics in colon and rectal surgery · 2016Review
- Renal and Gastrointestinal Considerations in Joint Replacement Surgery.Journal of nature and science · 2015Article
- Inflammatory bowel disease and thromboembolism.World journal of gastroenterology · 2014Review
- The impact of Hispanic ethnicity and race on post-surgical complications in patients with inflammatory bowel disease.Digestive diseases and sciences · 2014Article
- [Multimodal oncological therapy concepts, chemotherapy and immunosuppressive drugs: effects on surgical morbidity and mortality].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2013Review
- Article
- Biologic therapy and surgery for crohn disease.Clinics in colon and rectal surgery · 2013Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The perioperative management of patients with inflammatory bowel disease is challenging given the altered immune system that results from a variety of biologic and immunomodulator therapies. Clinicians are often faced with challenges and complicated equations when deciding on the type and dose of medication. To understand the effect of these medications and review the evidence regarding the management of these medications in the perioperative setting, a PubMed-based literature search (January 1, 1960, through April 1, 2011) was conducted using the following search terms: perioperative management, risk, outcome, inflammatory bowel disease, ulcerative colitis, Crohn's disease, aminosalicylates, glucocorticoids, purine analogues, cyclosporine, methotrexate, biologic therapy, infliximab, and thromboembolism. The 414 articles identified were manually sorted to exclude those that did not address perioperative risk, outcomes, and medications in the abstracts, yielding 84 articles for review. Additional references were obtained from the citations within the retrieved articles. This review surveys the findings of the selected articles and presents guidelines and resources for perioperative medication management for patients with inflammatory bowel disease undergoing surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.